Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (331-340 of 504) with videos related to

Pageof 51
Sort By:
International Journal of Cancer|September 26, 2018
Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancerFelix Bormann, Sebastian Stinzing, Sascha Tierling, et al.
Head & Neck|February 27, 2016
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancerAnnette Affolter, Marie-France Muller, Katharina Sommer, et al.
Cell Reports|December 3, 2014
Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammationAndreas Gewies, Oliver Gorka, Hanna Bergmann, et al.
Molecular Oncology|June 5, 2015
Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinomaPilar Bayo, Adriana Jou, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
British Journal of Cancer|October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classificationBjörn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, et al.
Scientific Reports|November 17, 2018
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancerGabriele Schricker, Rudolf Napieralski, Aurelia Noske, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Pageof 51

Showing results (331-340 of 504) with videos related to

Sort By:
Pageof 51
International Journal of Cancer|September 26, 2018
Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancerFelix Bormann, Sebastian Stinzing, Sascha Tierling, et al.
Head & Neck|February 27, 2016
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancerAnnette Affolter, Marie-France Muller, Katharina Sommer, et al.
Cell Reports|December 3, 2014
Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammationAndreas Gewies, Oliver Gorka, Hanna Bergmann, et al.
Molecular Oncology|June 5, 2015
Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinomaPilar Bayo, Adriana Jou, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
British Journal of Cancer|October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classificationBjörn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, et al.
Scientific Reports|November 17, 2018
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancerGabriele Schricker, Rudolf Napieralski, Aurelia Noske, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Pageof 51